Casdin Capital, LLC

Casdin Capital, LLC

Asset ManagementVenture Capital FirmGeneral Partner (GP)Direct Investor
Compliant with U.S. Gramm-Leach-Bliley Act and Fair Credit Reporting Act.

Casdin Capital, LLC is a New York-based research investment firm focused on innovations in molecular medicine reshaping Life Sciences and healthcare, with over $2.4 billion under management. The firm collaborates with industry leaders to fuel their visions, emphasizing long-term returns and disruptive technologies.

Founded

2011

Ownership

Privately held

Risk Profile

Long-term perspective with a focus on transformative opportunities in healthcare and biotechnology.

Location

New York, Ny, United States

About

Mission

We believe that great medicines lead to great investments, focusing on transformative potential in Life Sciences and leveraging advancements in molecular information to create value.

Values

Principled, Farsighted, Knowledgeable, Reflective, Consistent, Disciplined, Engaged.

Track Record

Team Experience

Decades of experience in the Life Sciences sector.

Notable Achievements

Investments in notable ventures such as 23andMe, Adaptive Biotechnologies, and AbSci.

Project Track Record

Investments in transformative healthcare companies such as 4D Molecular Therapeutics, Alector, and AmplifyBio.

Get Full Profile

Access complete investment history, team details, portfolio companies, and direct contact information.

Unlock Full Access

Headquarters

New York, Ny, United States

Legal & Compliance

Compliant with U.S. Gramm-Leach-Bliley Act and Fair Credit Reporting Act.

LP Database

Access 150,000+ investor profiles

Get complete access to our database of investment firms with detailed profiles, contact information, investment preferences, and AI-powered matching.

150K+
Investor Profiles
40K+
Investment Firms
10x
Faster Fundraising
500+
Fund Managers